Author’s reply to MintzesBMJ 2011; 343 doi: http://dx.doi.org/10.1136/bmj.d4904 (Published 02 August 2011) Cite this as: BMJ 2011;343:d4904
- Joanne M Shaw, chairman1
- 1Datapharm Communications Limited, Leatherhead, Surrey, UK
I support Mintzes’ concern about protecting the public from covert drugs promotion.1 2 But her fear and dislike of the drug industry has blinded her to the realisation that the control of information by well intentioned health professionals is unhelpful to patients. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial